EMN

Eastman Chemical Company - Q1 2008 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2008. Eastman Chemical Company is a large accelerated filer engaged in the production of specialty chemicals, intermediates, and performance polymers. The reporting period includes the completion of the sale of its European PET (polyethylene terephthalate) business, which is classified as discontinued operations.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 6% year-over-year, driven primarily by higher selling prices (10% effect) which offset lower volumes (-6% effect). Excluding transition sales and divested assets, organic sales grew 9%.
• Profitability: Operating earnings rose 9% to $168 million. Gross margin expanded to 19.5% due to improved performance in the Performance Polymers and Fibers segments, despite raw material and energy costs increasing by over $150 million compared to Q1 2007.
• Discontinued Operations: The company recognized an $18 million gain (net of tax) from the sale of its PET facilities in the Netherlands and UK. This contrasts with a $13 million loss on disposal in Q1 2007 related to the sale of its Spanish PET facility.
• Restructuring Charges: Q1 2008 included $17 million in asset impairments and restructuring charges, primarily severance and pension costs related to closing a UK site. Q1 2007 had no such charges.
• Cash Flow: Operating cash flow usage improved to $53 million from $66 million in the prior year, largely due to the absence of a $100 million pension contribution made in Q1 2007. Investing cash flow turned positive ($182 million) due to $323 million in proceeds from asset sales.

Guidance, Outlook, and Risks

• 2008 Outlook: Management expects capital spending to exceed $600 million, focused on industrial gasification projects, debottlenecking the South Carolina PET facility, and expanding acetate tow capacity. The effective tax rate is expected to be approximately 34%.
• Segment Margins: The PCI segment is expected to maintain operating margins at the high end of the 5-10% range. The CASPI segment is expected to maintain margins at the low end of the 15-20% range.
• Strategic Actions: The company plans to eliminate approximately $30 million in annual costs at the South Carolina site by mid-2008 and expects to complete the conversion of 50,000 metric tons of PET capacity to copolyester in the Specialty Plastics segment.
• Risks: Key risks include volatility in raw material and energy costs, global economic uncertainty, and the ability to pass price increases to customers. The company also faces potential environmental liabilities and ongoing asbestos litigation, though management does not believe these will have a material adverse effect.

Investor Verification Checklist

• Discontinued Operations Impact: Verify the sustainability of earnings excluding the one-time $18 million gain from the European PET divestiture.
• Raw Material Costs: Assess the company's ability to maintain gross margins given the >$150 million increase in raw material and energy costs year-over-year.
• Capital Expenditures: Monitor the execution and financing of the >$600 million capital spending plan, particularly the industrial gasification projects.
• Share Repurchases: Note the aggressive buyback program, with $245 million spent in Q1 2008 alone, reducing cash reserves.
• Working Capital: Review the seasonal build-up in inventory ($116 million increase in cash used) and its impact on future operating cash flows.